Touchon Pascal
SEC CIK 1780060 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | Pres, CEO, Dir | 78.0K | — | $943.6K | 19 | 2021-08-17 | 2025-06-10 |
Most active insiders at ATRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | EcoR1 Capital, LLC | 10% | $4.74M | — |
| 2 | Panacea Innovation Ltd | 10% | — | $3.17M |
| 3 | Cherry Brian N | Dir | $1000.0K | — |
| 4 | Huang James | Dir, 10% | — | $489.0K |
| 5 | Nguyen AnhCo | Pres, CEO, Dir | — | $142.4K |
| 6 | Grant-Huerta Yanina | CAO | — | $56.5K |
| 7 | Ciongoli Gregory Austin | Dir, 10%, See Remarks | — | — |
| 8 | Redmile Group, LLC | Dir | — | — |
| 9 | Fust Matthew K | Dir | — | — |
| 10 | HEIDEN WILLIAM K | Dir | — | — |
Touchon Pascal made no open-market trades at ATRA in the last 12 months.
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-12 | 2025-06-10 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Dir | A - Grant | $0.00 | +7,828 | 78.0K | +11% | $0 | |
| M | 2024-08-20 | 2024-08-16 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $6.63 | -3,038 | 70.4K | -4% | -$20.1K |
| 2024-05-20 | 2024-05-16 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $0.62 | -81.5K | 1.83M | -4% | -$50.5K | |
| 2024-03-06 | 2024-03-04 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $0.72 | -24.8K | 1.91M | -1% | -$17.9K | |
| 2024-01-09 | 2024-01-08 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | A - Grant | $0.00 | +1.28M | 1.94M | +195% | $0 | |
| 2023-11-20 | 2023-11-16 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $0.39 | -20.4K | 655.5K | -3% | -$7,960 | |
| M | 2023-08-18 | 2023-08-16 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $1.65 | -30.8K | 685.2K | -4% | -$50.8K |
| 2023-06-29 | 2023-06-27 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $1.66 | -14.3K | 706.7K | -2% | -$23.7K | |
| 2023-05-18 | 2023-05-16 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $2.04 | -29.8K | 721.0K | -4% | -$60.7K | |
| 2023-03-06 | 2023-03-02 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $3.63 | -15.7K | 750.7K | -2% | -$56.9K | |
| D | 2023-03-03 | 2023-03-01 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | A - Grant | $0.00 | +324.7K | 766.4K | +74% | $0 |
| 2022-11-18 | 2022-11-16 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $4.49 | -15.6K | 441.7K | -3% | -$70.0K | |
| 2022-08-18 | 2022-08-16 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $5.04 | -14.8K | 457.3K | -3% | -$74.6K | |
| 2022-06-29 | 2022-06-27 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $7.20 | -14.2K | 472.1K | -3% | -$102.4K | |
| 2022-05-19 | 2022-05-17 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $5.32 | -13.9K | 486.3K | -3% | -$74.0K | |
| D | 2022-03-03 | 2022-03-01 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $9.86 | -8,828 | 500.2K | -2% | -$87.0K |
| D | 2022-03-03 | 2022-03-01 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | A - Grant | $0.00 | +180.6K | 509.1K | +55% | $0 |
| 2021-11-18 | 2021-11-16 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $17.12 | -8,402 | 328.5K | -2% | -$143.8K | |
| 2021-08-19 | 2021-08-17 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO, Dir | S - Sale | $12.53 | -8,223 | 336.9K | -2% | -$103.0K |
Purchase Sale Sale after option exercise All abbreviations